Additional immunophenotypic markers useful in lineage assignment or subtyping of AML: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 38: | Line 38: | ||
!colspan="2" <span style="font-size:100%; colour:white; text-align:left; border: 1px solid black; background:lightgrey">|'''4. Additional markers Features associated with megakaryocytic differentiation'''</span><span style="font-size:90%; text-align:left; background:white"> | !colspan="2" <span style="font-size:100%; colour:white; text-align:left; border: 1px solid black; background:lightgrey">|'''4. Additional markers Features associated with megakaryocytic differentiation'''</span><span style="font-size:90%; text-align:left; background:white"> | ||
|- | |- | ||
|colspan="2" style = "font-size:90%; color:black; background:#ddeee1" |Most often [[CD34]], [[CD45]] and [[HLA-DR]] are weak or negative, although [[CD13]] and [[CD33]] may be expressed | |||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |'''[[CD41]]''' | |colspan="1" style = "font-size:90%; color:black;" |'''[[CD41]]''' |
Revision as of 18:16, 20 December 2023
Table: Marker patterns that can contribute to diagnosis or subtyping in less common cases
1. Additional markers that may support granulocytic maturation | |
---|---|
Standard markers in AML generally allow assignment for granulocytic cases, other markers may be less specific | |
CD11b | A marker of both granulocytic and monocytic maturation, this marker has previously been associated with less good outcome in a number of studies |
2. Additional markers that may support monocytic maturation | |
Standard markers in AML generally allow assignment for granulocytic cases, other markers may be less specific | |
CD11c | This marker is most associated with monocytic maturation in AML being fairly well corellated with CD11B, but overall probably less specific for monocytic differentiation that CD14 |
3. Additional markers Features associated with erythroid differentiation | |
Most often AML with erythroid maturation will express CD34, while CD45 and HLA-DR are weak or negative. CD117 and CD36 are generally expressed. There may be some expression of platelet markers in some cases. | |
CD71 | Frequently expressed though not fully lineage specific |
CD235 | A good marker of erythroid differentiation but acquired late and therefore may not be expressed |
4. Additional markers Features associated with megakaryocytic differentiation | |
Most often CD34, CD45 and HLA-DR are weak or negative, although CD13 and CD33 may be expressed | |
CD41 | Platelet glycoprotein IIbIIIa |
CD61 | Platelet glycoprotein IIIa |
CD36 | Relatively non-specific (seen in erythroid and monocytic leukaemias) but often strongly expressed
|